{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:42:42Z","timestamp":1792762962250,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100017655","name":"Incyte","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"DOI":"10.1007\/s13555-026-01952-2","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:30:49Z","timestamp":1792762249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Current Challenges in Atopic Dermatitis: An Italian Delphi Consensus with a Special Focus on Moderate Disease"],"prefix":"10.1007","author":[{"given":"Antonio","family":"Costanzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-0839","authenticated-orcid":false,"given":"Anna","family":"Campanati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Mariel","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampiero","family":"Girolomoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cataldo","family":"Patruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pezzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ribero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Stingeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Marzona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Politi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AD Delphi Working group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Susca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Arese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Leporati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"di Vico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Romita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Martina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Atzori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Zussino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Macchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Spigariolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Giacalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Hansel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elettra","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bertoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katiuscia","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Narcisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Facheris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Pisapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Amerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiacomo","family":"Calzavara Pinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Antiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Dattola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Galluzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Diotallevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Gioacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Bianchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolo","family":"Gori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fagotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Trave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"1952_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaip.2019.06.044","volume":"8","author":"AB Fishbein","year":"2020","unstructured":"Fishbein AB, Silverberg JI, Wilson EJ, Ong PY. Update on atopic dermatitis: diagnosis, severity assessment, and treatment selection. J Allergy Clin Immunol Pract. 2020;8:91\u2013101. https:\/\/doi.org\/10.1016\/j.jaip.2019.06.044.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1952_CR2","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1007\/s13555-022-00777-z","volume":"12","author":"CE Kleyn","year":"2022","unstructured":"Kleyn CE, Barbarot S, Reed C, et al. Burden of moderate to severe atopic dermatitis in adults from France, Italy, and the UK: patient-reported outcomes and treatment patterns. Dermatol Ther (Heidelb). 2022;12:1947\u201365. https:\/\/doi.org\/10.1007\/s13555-022-00777-z.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1952_CR3","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/jdv.16892","volume":"34","author":"A Wollenberg","year":"2020","unstructured":"Wollenberg A, Christen-Z\u00e4ch S, Taieb A, et al. ETFAD\/EADV eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children. J Eur Acad Dermatol Venereol. 2020;34:2717\u201344. https:\/\/doi.org\/10.1111\/jdv.16892.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1952_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.23736\/S2784-8671.24.07664-3","volume":"159","author":"G Argenziano","year":"2024","unstructured":"Argenziano G, Cusano F, Corazza M, et al. Italian S3-guideline on the treatment of atopic eczema\u2014part 1: systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA). Ital J Dermatol Venerol. 2024;159:223\u201350. https:\/\/doi.org\/10.23736\/S2784-8671.24.07664-3.","journal-title":"Ital J Dermatol Venerol."},{"key":"1952_CR5","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/jdv.18429","volume":"36","author":"A Wollenberg","year":"2022","unstructured":"Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema\u2014part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022;36:1904\u201326. https:\/\/doi.org\/10.1111\/jdv.18429.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1952_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s40257-023-00819-y","volume":"25","author":"L Stingeni","year":"2024","unstructured":"Stingeni L, Chiricozzi A, Calzavara-Pinton P, et al. AtopyReg. Am J Clin Dermatol. 2024;25:149\u201360. https:\/\/doi.org\/10.1007\/s40257-023-00819-y.","journal-title":"Am J Clin Dermatol"},{"key":"1952_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/bmj.311.7001.376\/","volume":"311","author":"J Jones","year":"1995","unstructured":"Jones J, Hunter D. Consensus methods for medical and health services research. BMJ. 1995;311:376\u201380. https:\/\/doi.org\/10.1136\/bmj.311.7001.376\/.","journal-title":"BMJ"},{"key":"1952_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/DER.0000000000000895","volume":"33","author":"JM Hanifin","year":"2022","unstructured":"Hanifin JM, Baghoomian W, Grinich E, Leshem YA, Jacobson M, Simpson EL. The eczema area and severity index-A PRACTICAL GUIDE. Dermatitis. 2022;33:187\u201392. https:\/\/doi.org\/10.1097\/DER.0000000000000895.","journal-title":"Dermatitis"},{"key":"1952_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.anai.2018.07.004","volume":"121","author":"JI Silverberg","year":"2018","unstructured":"Silverberg JI, Gelfand JM, Margolis DJ, et al. Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis. Ann Allergy Asthma Immunol. 2018;121:464\u20138.e3. https:\/\/doi.org\/10.1016\/j.anai.2018.07.004.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1952_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/bjd.17683","volume":"181","author":"JI Silverberg","year":"2019","unstructured":"Silverberg JI, Gelfand JM, Margolis DJ, et al. Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults. Br J Dermatol. 2019;181:554\u201365. https:\/\/doi.org\/10.1111\/bjd.17683.","journal-title":"Br J Dermatol"},{"key":"1952_CR11","doi-asserted-by":"publisher","first-page":"e544","DOI":"10.1111\/ajd.14619","volume":"66","author":"JC Su","year":"2025","unstructured":"Su JC, Townsend A, Gibson KA, Kauffman L, Colman S, Newson RS. Characteristics, disease burden and healthcare resource use of moderate and severe atopic dermatitis in Australia. Australas J Dermatol. 2025;66:e544\u201352. https:\/\/doi.org\/10.1111\/ajd.14619.","journal-title":"Australas J Dermatol"},{"key":"1952_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40257-025-00966-4","volume":"26","author":"JF Merola","year":"2025","unstructured":"Merola JF, Weidinger S, Tan SY, Rahawi K, Gray C. Defining, \u201cFlares\u201d in atopic dermatitis: a narrative review. Am J Clin Dermatol. 2025;26:905\u201321. https:\/\/doi.org\/10.1007\/s40257-025-00966-4.","journal-title":"Am J Clin Dermatol"},{"key":"1952_CR13","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/jamadermatol.2022.1906","volume":"158","author":"R Elsawi","year":"2022","unstructured":"Elsawi R, Dainty K, Smith Begolka W, et al. The multidimensional burden of atopic dermatitis among adults: results from a large national survey. JAMA Dermatol. 2022;158:887\u201392. https:\/\/doi.org\/10.1001\/jamadermatol.2022.1906.","journal-title":"JAMA Dermatol"},{"key":"1952_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1712757","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang L, Peng G, Wang M, Niyonsaba F, Gao X. Beyond the blockade: unmet needs in systemic targeted atopic dermatitis therapy. Front Immunol. 2025;16:1712757. https:\/\/doi.org\/10.3389\/fimmu.2025.1712757.","journal-title":"Front Immunol"},{"key":"1952_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40257-023-00810-7","volume":"25","author":"G Yosipovitch","year":"2024","unstructured":"Yosipovitch G, Gooderham MJ, St\u00e4nder S, et al. Interpreting the relationship among itch, sleep, and work productivity in patients with moderate-to-severe atopic dermatitis: a post hoc analysis of JADE MONO-2. Am J Clin Dermatol. 2024;25:127\u201338. https:\/\/doi.org\/10.1007\/s40257-023-00810-7.","journal-title":"Am J Clin Dermatol"},{"key":"1952_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.alit.2022.04.003","volume":"71","author":"M Tominaga","year":"2022","unstructured":"Tominaga M, Takamori K. Peripheral itch sensitization in atopic dermatitis. Allergol Int. 2022;71:265\u201377. https:\/\/doi.org\/10.1016\/j.alit.2022.04.003.","journal-title":"Allergol Int"},{"key":"1952_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s13555-022-00700-6","volume":"12","author":"T Luger","year":"2022","unstructured":"Luger T, Romero WA, Gruben D, Smith TW, Cha A, Neary MP. Clinical and humanistic burden of atopic dermatitis in Europe: analyses of the National Health and Wellness Survey. Dermatol Ther. 2022;12:949\u201369. https:\/\/doi.org\/10.1007\/s13555-022-00700-6.","journal-title":"Dermatol Ther"},{"key":"1952_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s13555-025-01602-z","volume":"16","author":"O Noor","year":"2026","unstructured":"Noor O, Liu J, Sturm D, et al. Use of ruxolitinib cream results in economic benefits compared with dupilumab in treatment of patients with atopic dermatitis meeting severity thresholds for systemic therapy. Dermatol Ther (Heidelb). 2026;16:535\u201347. https:\/\/doi.org\/10.1007\/s13555-025-01602-z.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1952_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.54254\/2753-8818\/2025.AU25959","volume":"124","author":"S Wang","year":"2025","unstructured":"Wang S. Regulation, reimbursement, and economic access: a health policy perspective on dupilumab in different countries\u2019 health systems. Theor Nat Sci. 2025;124:84\u20138. https:\/\/doi.org\/10.54254\/2753-8818\/2025.AU25959.","journal-title":"Theor Nat Sci"},{"key":"1952_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262311487","author":"A Prados-Carmona","year":"2025","unstructured":"Prados-Carmona A, Husein-ElAhmed H, Navarro-Trivi\u00f1o FJ, Ruiz-Villaverde R. From pathways to patients in atopic dermatitis: advanced systemic therapies. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms262311487.","journal-title":"Int J Mol Sci"},{"key":"1952_CR21","doi-asserted-by":"publisher","first-page":"582","DOI":"10.2340\/00015555-0933","volume":"90","author":"SH Oh","year":"2010","unstructured":"Oh SH, Bae BG, Park CO, et al. Association of stress with symptoms of atopic dermatitis. Acta Derm Venereol. 2010;90:582\u20138. https:\/\/doi.org\/10.2340\/00015555-0933.","journal-title":"Acta Derm Venereol"},{"key":"1952_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00403-024-03130-w","volume":"316","author":"A Wollenberg","year":"2024","unstructured":"Wollenberg A, Gooderham M, Katoh N, et al. Patient-reported burden in adults with atopic dermatitis: an international qualitative study. Arch Dermatol Res. 2024;316:380. https:\/\/doi.org\/10.1007\/s00403-024-03130-w.","journal-title":"Arch Dermatol Res"},{"key":"1952_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.12932\/AP-010221-1050","volume":"39","author":"K Kulthanan","year":"2021","unstructured":"Kulthanan K, Tuchinda P, Nitiyarom R, et al. Clinical practice guidelines for the diagnosis and management of atopic dermatitis. Asian Pac J Allergy Immunol. 2021;39:145\u201355. https:\/\/doi.org\/10.12932\/AP-010221-1050.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"1952_CR24","doi-asserted-by":"publisher","first-page":"204062232110667","DOI":"10.1177\/20406223211066728","volume":"13","author":"G Girolomoni","year":"2022","unstructured":"Girolomoni G, Bus\u00e0 VM. Flare management in atopic dermatitis: from definition to treatment. Ther Adv Chronic Dis. 2022;13:20406223211066730. https:\/\/doi.org\/10.1177\/20406223211066728.","journal-title":"Ther Adv Chronic Dis"},{"key":"1952_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jid.2016.07.012","volume":"137","author":"AM Drucker","year":"2017","unstructured":"Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the national eczema association. J Invest Dermatol. 2017;137:26\u201330. https:\/\/doi.org\/10.1016\/j.jid.2016.07.012.","journal-title":"J Invest Dermatol"},{"key":"1952_CR26","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/jdv.16003","volume":"34","author":"M de Bruin-Weller","year":"2020","unstructured":"de Bruin-Weller M, Gadkari A, Auziere S, et al. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada. J Eur Acad Dermatol Venereol. 2020;34:1026\u201336. https:\/\/doi.org\/10.1111\/jdv.16003.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1952_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13555-020-00459-8","volume":"11","author":"G Girolomoni","year":"2021","unstructured":"Girolomoni G, Luger T, Nosbaum A, et al. The economic and psychosocial comorbidity burden among adults with moderate-to-severe atopic dermatitis in Europe: analysis of a cross-sectional survey. Dermatol Ther (Heidelb). 2021;11:117\u201330. https:\/\/doi.org\/10.1007\/s13555-020-00459-8.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1952_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/bjd.20783","volume":"186","author":"J Puelles","year":"2022","unstructured":"Puelles J, Fofana F, Rodriguez D, Silverberg JI, et al. Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate-to-severe atopic dermatitis. Br J Dermatol. 2022;186:285\u201394. https:\/\/doi.org\/10.1111\/bjd.20783.","journal-title":"Br J Dermatol"},{"key":"1952_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.anai.2019.12.002","volume":"124","author":"D Lei","year":"2020","unstructured":"Lei D, Yousaf M, Janmohamed SR, et al. Validation of four single-item patient-reported assessments of sleep in adult atopic dermatitis patients. Ann Allergy Asthma Immunol. 2020;124:261\u20136. https:\/\/doi.org\/10.1016\/j.anai.2019.12.002.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1952_CR30","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jaad.2018.03.017","volume":"79","author":"ATM R\u00f8nnstad","year":"2018","unstructured":"R\u00f8nnstad ATM, Halling-Overgaard AS, Hamann CR, Skov L, Egeberg A, Thyssen JP. Association of atopic dermatitis with depression, anxiety, and suicidal ideation in children and adults: a systematic review and meta-analysis. J Am Acad Dermatol. 2018;79:448-56.e30. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.017.","journal-title":"J Am Acad Dermatol"},{"key":"1952_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1089\/derm.2022.29015.jsi","volume":"34","author":"JI Silverberg","year":"2023","unstructured":"Silverberg JI, Mohawk JA, Cirulli J, et al. Burden of disease and unmet needs in atopic dermatitis: results from a patient survey. Dermatitis. 2023;34:135\u201344. https:\/\/doi.org\/10.1089\/derm.2022.29015.jsi.","journal-title":"Dermatitis"},{"key":"1952_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2202288","volume":"34","author":"ED Bacci","year":"2023","unstructured":"Bacci ED, Correll JR, Pierce EJ, et al. Burden of adult atopic dermatitis and unmet needs with existing therapies. J Dermatol Treat. 2023;34:2202288. https:\/\/doi.org\/10.1080\/09546634.2023.2202288.","journal-title":"J Dermatol Treat"},{"key":"1952_CR33","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1111\/jdv.18515","volume":"37","author":"B Halioua","year":"2023","unstructured":"Halioua B, Bastien M, Taieb C, et al. Prevalence and predictors of perceived stigmatization in adult patients with moderate-to-severe atopic dermatitis in France. J Eur Acad Dermatol Venereol. 2023;37:e80\u20131. https:\/\/doi.org\/10.1111\/jdv.18515.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1952_CR34","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jaip.2023.03.011","volume":"11","author":"S Butala","year":"2023","unstructured":"Butala S, Castelo-Soccio L, Seshadri R, et al. Biologic versus small molecule therapy for treating moderate to severe atopic dermatitis: clinical considerations. J Allergy Clin Immunol Pract. 2023;11:1361\u201373. https:\/\/doi.org\/10.1016\/j.jaip.2023.03.011.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1952_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/jamadermatol.2022.0455","volume":"158","author":"AM Drucker","year":"2022","unstructured":"Drucker AM, Morra DE, Prieto-Merino D, et al. Systemic immunomodulatory treatments for atopic dermatitis: update of a living systematic review and network meta-analysis. JAMA Dermatol. 2022;158:523\u201332. https:\/\/doi.org\/10.1001\/jamadermatol.2022.0455.","journal-title":"JAMA Dermatol"},{"key":"1952_CR36","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jaip.2020.11.034","volume":"9","author":"T Ratchataswan","year":"2021","unstructured":"Ratchataswan T, Banzon TM, Thyssen JP, Weidinger S, Guttman-Yassky E, Phipatanakul W. Biologics for treatment of atopic dermatitis: current status and future prospect. J Allergy Clin Immunol Pract. 2021;9:1053\u201365. https:\/\/doi.org\/10.1016\/j.jaip.2020.11.034.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1952_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3238\/arztebl.m2023.0011","volume":"120","author":"A Wollenberg","year":"2023","unstructured":"Wollenberg A, Werfel T, Ring J, Ott H, Gieler U, Weidinger S. Atopic dermatitis in children and adults\u2014diagnosis and treatment. Dtsch Arztebl Int. 2023;120:224\u201334. https:\/\/doi.org\/10.3238\/arztebl.m2023.0011.","journal-title":"Dtsch Arztebl Int"},{"key":"1952_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/ddg.15230","volume":"22","author":"T Werfel","year":"2024","unstructured":"Werfel T, Heratizadeh A, Aberer W, et al. S3 guideline atopic dermatitis: part 1\u2014general aspects, topical and non-drug therapies, special patient groups. J Dtsch Dermatol Ges. 2024;22:137\u201353. https:\/\/doi.org\/10.1111\/ddg.15230.","journal-title":"J Dtsch Dermatol Ges"},{"key":"1952_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046476","volume":"11","author":"E Axon","year":"2021","unstructured":"Axon E, Chalmers JR, Santer M, et al. Safety of topical corticosteroids in atopic eczema: an umbrella review. BMJ Open. 2021;11:e046476. https:\/\/doi.org\/10.1136\/bmjopen-2020-046476.","journal-title":"BMJ Open"},{"key":"1952_CR40","doi-asserted-by":"publisher","unstructured":"Sridharan K. Drugs associated with tachyphylaxis: results from a retrospective pharmacovigilance study using disproportionality analysis. Eur J Hosp Pharm. 2026;33(2):183\u20136. https:\/\/doi.org\/10.1136\/ejhpharm-2024-004353.","DOI":"10.1136\/ejhpharm-2024-004353"},{"key":"1952_CR41","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/bjd.15928","volume":"178","author":"AM Drucker","year":"2018","unstructured":"Drucker AM, Eyerich K, de Bruin-Weller MS, et al. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. Br J Dermatol. 2018;178:768\u201375. https:\/\/doi.org\/10.1111\/bjd.15928.","journal-title":"Br J Dermatol"},{"key":"1952_CR42","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.anai.2022.03.004","volume":"128","author":"S Butala","year":"2022","unstructured":"Butala S, Paller AS. Optimizing topical management of atopic dermatitis. Ann Allergy Asthma Immunol. 2022;128:488\u2013504. https:\/\/doi.org\/10.1016\/j.anai.2022.03.004.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1952_CR43","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1004a94","volume":"10","author":"VR Mudaliyar","year":"2020","unstructured":"Mudaliyar VR, Pathak A, Dixit A, Kumar SS. An open-label prospective study to compare the efficacy and safety of topical fluticasone versus tacrolimus in the proactive treatment of atopic dermatitis. Dermatol Pract Concept. 2020;10:e2020094. https:\/\/doi.org\/10.5826\/dpc.1004a94.","journal-title":"Dermatol Pract Concept"},{"key":"1952_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013870.pub2","volume":"10","author":"AH Musters","year":"2021","unstructured":"Musters AH, Mashayekhi S, Harvey J, et al. Phototherapy for atopic eczema. Cochrane Database Syst Rev. 2021;10:CD013870. https:\/\/doi.org\/10.1002\/14651858.CD013870.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"1952_CR45","doi-asserted-by":"publisher","first-page":"133","DOI":"10.23736\/S0392-0488.17.05892-8","volume":"153","author":"P Calzavara Pinton","year":"2018","unstructured":"Calzavara Pinton P, Cristaudo A, Foti C, et al. Diagnosis and management of moderate to severe adult atopic dermatitis: a consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA). G Ital Dermatol Venereol. 2018;153:133\u201345. https:\/\/doi.org\/10.23736\/S0392-0488.17.05892-8.","journal-title":"G Ital Dermatol Venereol"},{"key":"1952_CR46","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1111\/jdv.17351","volume":"35","author":"JI Silverberg","year":"2021","unstructured":"Silverberg JI, Thyssen JP, Fahrbach K, et al. Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: a systematic literature review and network meta-analysis. J Eur Acad Dermatol Venereol. 2021;35:1797\u2013810. https:\/\/doi.org\/10.1111\/jdv.17351.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1952_CR47","doi-asserted-by":"publisher","first-page":"607","DOI":"10.23736\/S2784-8671.24.07946-5","volume":"159","author":"M Maurelli","year":"2024","unstructured":"Maurelli M, Girolomoni G, Gisondi P. Cost per responder analysis of abrocitinib versus dupilumab in moderate to severe atopic dermatitis. Ital J Dermatol Venerol. 2024;159:607\u201311. https:\/\/doi.org\/10.23736\/S2784-8671.24.07946-5.","journal-title":"Ital J Dermatol Venerol"},{"key":"1952_CR48","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/13696998.2023.2255495","volume":"26","author":"E Johansson","year":"2023","unstructured":"Johansson E, Giovannitti M, Mezzetti M, Lu N, Sabatino S. Cost-effectiveness analysis of baricitinib versus dupilumab for moderate to severe atopic dermatitis: an Italian healthcare system perspective. J Med Econ. 2023;26:1155\u201366. https:\/\/doi.org\/10.1080\/13696998.2023.2255495.","journal-title":"J Med Econ"},{"key":"1952_CR49","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.anai.2020.07.005","volume":"125","author":"MR Hong","year":"2020","unstructured":"Hong MR, Lei D, Yousaf M, et al. A real-world study of the longitudinal course of adult atopic dermatitis severity in clinical practice. Ann Allergy Asthma Immunol. 2020;125:686-92.e3. https:\/\/doi.org\/10.1016\/j.anai.2020.07.005.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1952_CR50","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1080\/09546634.2019.1655137","volume":"31","author":"MJ Cork","year":"2020","unstructured":"Cork MJ, Danby SG, Ogg GS. Atopic dermatitis epidemiology and unmet need in the United Kingdom. J Dermatolog Treat. 2020;31:801\u20139. https:\/\/doi.org\/10.1080\/09546634.2019.1655137.","journal-title":"J Dermatolog Treat"},{"key":"1952_CR51","doi-asserted-by":"publisher","first-page":"adv00830","DOI":"10.2340\/actadv.v102.3932","volume":"102","author":"M Augustin","year":"2022","unstructured":"Augustin M, Costanzo A, Pink A, et al. Real-world treatment patterns and treatment benefits among adult patients with atopic dermatitis: results from the Atopic Dermatitis Patient Satisfaction and Unmet Need Survey. Acta Derm Venereol. 2022;102:adv00830. https:\/\/doi.org\/10.2340\/actadv.v102.3932.","journal-title":"Acta Derm Venereol"},{"key":"1952_CR52","doi-asserted-by":"publisher","first-page":"adv42773","DOI":"10.2340\/actadv.v105.42773","volume":"105","author":"S M\u00fcller","year":"2025","unstructured":"M\u00fcller S, Zeidler C, Mess C, et al. Patient needs and treatment goals in chronic atopic pruritus: does eczema make a difference? Acta Derm Venereol. 2025;105:adv42773. https:\/\/doi.org\/10.2340\/actadv.v105.42773.","journal-title":"Acta Derm Venereol"},{"key":"1952_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13643-021-01687-5","volume":"10","author":"M Rocholl","year":"2021","unstructured":"Rocholl M, Ludewig M, Brakemeier C, John SM, Wilke A. Illness perceptions of adults with eczematous skin diseases: a systematic mixed studies review. Syst Rev. 2021;10:141. https:\/\/doi.org\/10.1186\/s13643-021-01687-5.","journal-title":"Syst Rev"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01952-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01952-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01952-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:30:50Z","timestamp":1792762250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01952-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":53,"alternative-id":["1952"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01952-2","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Antonio Costanzo has served as paid speaker, consultant or advisor for Abbvie, Almirall, Leo Pharma, Galderma, Novartis, UCB, Boehringer, Amgen, Eli Lilly, BMS, and Takeda. Anna Campanati has served as speaker, consultant or advisor for Abbvie, Almirall, Leo Pharma, Galderma, Novartis, UCB, Boehringer, Amgen, Eli Lilly, BMS, Galderma, and Sanofi. Maria Esposito has served as speaker and\/or consultant for AbbVie, Amgen, Almirall, Boehringer Ingelheim, Eli Lilly, Janssen, LEO Pharma, Novartis, Pfizer, UCB, and Sanofi-Regeneron. Silvia Mariel Ferrucci has served as principal investigator, speaker, or advisory board member for Abbvie, Amgen, Almirall, Galderma, Incyte, Nectar, Novartis, Eli Lilly, Uriage, Pfizer, Sanofi, Leo Pharma, and Roche. Lucia Politi and Irene Marzona work for Helaglobe, which has served as consultant for Abiogen, Alexion, AOP health, Apellis, Convatec, Daichii-sankyo, Doctolib, Fidia, Gore, GSK, Hologic, Lilly, Mirum, Molteni, Orphalan, Recordati rare diseases, SOBI, Theramex, Tillotts, UCB, Uriach, and Visufarma. Cataldo Patruno has acted as consultant, speaker, advisory board member, and\/or investigator for Abbvie, Almirall, Amgen, Chiesi, Galderma, La Roche-Posay, LeoPharma, Lilly, Novartis, Pfizer, Pierre Fabre, Regeneron, and Sanofi. Simone Ribero has received research grant\/travel\/consultancy from Abbvie, Allmiral, Leo Pharma, J&J, L\u2019Oreal, Sanofi Regeneron, Sandoz, UCB, Eli Lilly, Novartis, BMS, and Incyte. Elena Pezzolo has received research grant\/travel\/consultancy funding from AbbVie, Eli Lilly, Pfizer, LEO Pharma, Almirall, Sanofi Regeneron, Galderma, Novartis, J&J, and BMS. Mariateresa Rossi has served as a speaker\/consultant for Sanofi, Leo Pharma, AbbVie, Almirall, Pfizer, Galderma, and L'Or\u00e9al. Maddalena Napolitano reports consulting fees from Abbvie, Lilly, Pfizer, LEO Pharma, Almirall, and Sanofi; payment\/honoraria from Abbvie, Lilly, LEO Pharma, Novartis, Almirall, Pfizer, and Sanofi, and participation on Data Safety Monitoring Board\/Advisory Board from Lilly, Sanofi, LEO Pharma, Abbvie, and Almirall; and support for attending meetings\/travel from Lilly, Sanofi, and Abbvie. Giampiero Girolomoni has received personal fees from AbbVie, Almirall, Boehringer-Ingelheim, Bristol-Myers Squibb, Galderma, Eli-Lilly, Incyte, Johnson & Johnson Innovative Medicine, Leo Pharma, Merck Serono, Novartis, Pfizer, Samsung bioepis, and Sanofi. Luca Stingeni has been the principal investigator in clinical trials sponsored by and\/or and has received personal fees for participation in advisory boards from AbbVie, Leo Pharma, Lilly, Novartis, Pfizer, and Sanofi. Anna Campanati, Maddalena Napolitano, and Mariateresa Rossi are Editorial Board members of\n                      Dermatology and Therapy\n                      . Anna Campanati, Maddalena Napolitano and Mariateresa Rossi were not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board approval was exempted for this study as its procedures did not include human subjects. All the dermatologists who participated in the consensus gave consent to its publication.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}